Dr. Anna Gaddy, MD

Dr. Gaddy practices at Froedtert Hospital in Milwaukee, Wisconsin, part of Froedtert ThedaCare Health.

Dr. Gaddy's NPI, 1619326980, was assigned on June 8, 2016. Dr. Gaddy graduated from Indiana University School Of Medicine in 2015. Dr. Gaddy's Wisconsin license number on file is 75129.

Dr. Gaddy's primary practice is Froedtert Hospital, at 9200 W Wisconsin Ave, Milwaukee, WI 53226 in Milwaukee County. The practice phone is (414) 805-3000.

Dr. Gaddy's primary practice is Froedtert Hospital in Milwaukee, Wisconsin, part of Froedtert ThedaCare Health. The medical group on file is Froedtert & the Medical College of Wisconsin Community Physicians.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gaddy practices. Vendor and product names are available with a free account.

Nephrology is Dr. Gaddy's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Gaddy is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Gaddy's licenses on file in 2 states: Wisconsin and Indiana.

Dmand AI lists acute kidney failure and chronic kidney disease among the conditions Dr. Gaddy treats.

CMS data shows 339 Medicare services from Dr. Gaddy across 8 procedure codes in 2024, for 155 Medicare patients. Medicare paid $20,871 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 155 Medicare patients who saw Dr. Gaddy in 2024. The largest group is 75 to 84, with 50 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 35% are also on Medicaid. Their average risk score is 4.39, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Gaddy's median patient age at 66, with 56% women.

In 2024, Dr. Gaddy wrote 851 Medicare Part D claims for 150 patients. 76% of them were for generic drugs. CMS names the drug for 651 of them, across 20 drugs with 11 or more claims each, at $185,111 in total drug cost. In 2023, CMS named 550 claims across 19 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Gaddy for performance year 2024, reported as part of a group. Dr. Gaddy accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Gaddy as offering telehealth.

Dmand AI links 10 papers to Dr. Gaddy, published from 2010 to 2024. 2021 was the busiest year, with 3. The most frequent topics are Acute Kidney Injury, Calcium and Kidney. Dr. Gaddy's most frequent co-authors are Fredric L. Coe, Gates B. Colbert, MD and Michael Thomas Eadon, MD.

CMS Open Payments shows 35 general payments to Dr. Gaddy from 9 drug and device companies from 2018 to 2025. Consulting fees make up the largest share, 88% of the total. Otsuka Pharmaceutical Development & Commercialization, Inc. paid the most, $12,123.

Dr. Gaddy graduated from Indiana University School Of Medicine in 2015. Dr. Gaddy is a member of ASN and National Kidney Foundation.

Dr. Gaddy is in network with 17 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.